tiprankstipranks
Trending News
More News >
Genmab A/S (GMAB)
NASDAQ:GMAB
Advertisement

Genmab (GMAB) Similar Stocks

Compare
658 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Genmab
$22.98
$13.36B
11.23
-15.55%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioMarin Pharmaceutical
$58.00
$10.92B
17.27
-34.96%
20 Buy
4 Hold
0 Sell
Strong Buy
Exelixis
$38.47
$10.22B
18.46
46.22%
11 Buy
8 Hold
0 Sell
Moderate Buy
Incyte
$86.16
$16.82B
19.59
39.69%
11 Buy
8 Hold
1 Sell
Moderate Buy
United Therapeutics
$312.06
$13.63B
12.09
-3.41%
9 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$192.04
$11.87B
37.66%
16 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GMAB
Genmab
22.98
-3.97
-14.73%
BMRN
BioMarin Pharmaceutical
58.00
-31.53
-35.22%
EXEL
Exelixis
38.47
12.12
46.00%
INCY
Incyte
86.16
24.00
38.61%
UTHR
United Therapeutics
312.06
-8.93
-2.78%
ASND
Ascendis Pharma
192.04
53.20
38.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis